Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Recurrence 7Lymphoma, T-Cell, Peripheral 4Neoplasm Metastasis 3Lymphoma, T-Cell 3Sezary Syndrome 2Mycosis Fungoides 2Meningeal Carcinomatosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Lung Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Vitamin B 12 Deficiency 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Thrombocytopenia 1Stomach Neoplasms 1Smoking 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Papilloma 1Ovarian Neoplasms 1Neutropenia 1Neuralgia 1Neoplasms 1

Interventions

Tobacco Use Cessation Devices 4Surveys and Questionnaires 4Varenicline 2Tobacco Products 2Smoking Devices 2Ethanol 2Celecoxib 2zileuton 1olaparib 1Yoga 1Vitamin B 12 1Transcranial Direct Current Stimulation 1Restraint, Physical 1Radon 1Radiotherapy 1Patient Navigation 1Nicotine Replacement Therapy 1Motivational Interviewing 1Mindfulness-Based Stress Reduction 1Mindfulness 1Interviews as Topic 1Health 1Folic Acid 1Erlotinib Hydrochloride 1Cycloserine 1Cognitive Behavioral Therapy 1Cetuximab 1Bupropion 1Budesonide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Smoking × Vitamin B 12 × Clear all
NCT00606502 2021-03-05

Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment

Spectrum Pharmaceuticals, Inc

Phase 2 Completed
201 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡